SCHEDULE 13D/A: Kanen Wealth Management Group Reduces Stake in Quipt Home Medical Below 5%
Schedule 13D Amendment
Kanen Wealth Management LLC and its affiliated funds have filed an amended Schedule 13D, disclosing that their collective beneficial ownership in Quipt Home Medical Corp. has fallen below the 5% threshold as of May 20, 2025.
Summary
- This filing, Amendment No. 3 to the Schedule 13D, details changes in beneficial ownership of Quipt Home Medical Corp. Common Shares by Philotimo Fund, LP, Philotimo Focused Growth & Income Fund (PHLOX), Kanen Wealth Management LLC (KWM), and David L. Kanen.
- As of May 27, 2025, the reporting group collectively beneficially owned 1,930,527 Common Shares, representing approximately 4.4% of the 43,443,972 shares outstanding as of May 9, 2025.
- The reporting persons ceased to be beneficial owners of more than 5% of the Issuer's shares as of May 20, 2025.
- Individual beneficial ownership percentages are: Philotimo Fund, LP at 1.8% (786,453 shares), PHLOX at 2.5% (1,072,491 shares), and KWM at 4.4% (1,928,225 shares, including shares held by Philotimo, PHLOX, and Managed Accounts).
- Shares were acquired using working capital, funds for customer accounts, and potentially margin loans through open market transactions.
- The aggregate purchase price for the 786,453 shares beneficially owned by Philotimo was approximately $2,279,187, for the 1,072,491 shares by PHLOX was approximately $2,845,939, for the 69,281 shares in Managed Accounts was approximately $205,001, and for the 2,302 shares directly by Mr. Kanen was approximately $6,813.
- The reduction in stake resulted from various open market sales of common stock by all reporting persons between May 13, 2025, and May 21, 2025.
Sentiment
Score: 5
Explanation: The document is a factual regulatory filing detailing a change in beneficial ownership. It does not contain subjective language or performance metrics that would indicate a positive or negative sentiment regarding the company's operations or future prospects.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The reduction in a significant investor's stake below the 5% threshold could be interpreted by the market as a change in investment strategy or conviction by a large holder, potentially influencing the company's share price.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date as of which 43,443,972 shares were outstanding, as reported in the Issuer's Quarterly Report on Form 10-Q. |
| 05/12/2025 | Date Quipt Home Medical Corp.'s Quarterly Report on Form 10-Q was filed with the SEC. |
| 05/13/2025 | Date of common stock sales by Philotimo Fund, LP and Philotimo Focused Growth & Income Fund. |
| 05/20/2025 | Date of the event which required the filing of this statement (Reporting Persons ceased to be beneficial owners of more than 5% of shares). Also, date of common stock sales by all reporting persons. |
| 05/21/2025 | Date of common stock sales by all reporting persons. |
| 05/27/2025 | Date as of which beneficial ownership percentages were calculated for the filing. |
| 05/28/2025 | Date of signing the Schedule 13D Amendment No. 3. |
Keywords
Quipt Home Medical Corp., Schedule 13D, beneficial ownership, SEC filing, investment management, shareholder stake, common shares, Philotimo Fund, Kanen Wealth Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.